Oxidative stress and haemodialysis:: role of inflammation and duration of dialysis treatment

被引:202
作者
Nguyen-Khoa, T
Massy, ZA
De Bandt, JP
Kebede, M
Salama, L
Lambrey, G
Witko-Sarsat, V
Drüeke, TB
Lacour, B
Thévenin, M
机构
[1] Hop Necker Enfants Malad, INSERM, U507, F-75743 Paris 15, France
[2] Beauvais Hosp, Div Nephrol, Paris, France
关键词
advanced oxidation protein products (AOPP); glutathione; haemodialysis; highly sensitive C reactive protein assay; inflammation; oxidative stress; vitamins;
D O I
10.1093/ndt/16.2.335
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Oxidative stress has long been demonstrated in haemodialysis patients. However, the factors influencing their oxidative status have not been characterized extensively in these patients. Therefore, the present study was designed to investigate the influence of a large number of factors known to be associated with oxidative stress. Methods. In the present cross-sectional study, we determined the plasma levels of lipid and protein oxidation markers in 31 non-smoking haemodialysis patients and 18 non-smoking healthy subjects, together with various components of the antioxidant system at the plasma and erythrocyte level. Results, No influence of age, diabetes or iron overload on oxidative markers and plasma and erythrocyte antioxidant systems was detected in these haemodialysis patients. The lack of an association between iron overload and oxidative status map be related to the lower level of plasma ascorbate in haemodialysis patients, since ascorbate favours the generation of free iron from ferritin-bound iron. Interestingly, plasma C reactive protein (CRP) levels measured by highly sensitive CRP assay were correlated positively with plasma levels of thiobarbituric acid reactive substances (r = 0.38, P < 0.04) and negatively with plasma <alpha>-tocophorol levels (r = -0.36, P < 0.01). Moreover, significant inverse correlations were observed between duration of dialysis treatment and plasma levels of <alpha>-tocopherol (r = -0.49, P < 0.02) and ubiquinol (r = -0.40, P < 0.05). Conclusions. Our results suggest that inflammatory status and duration of dialysis treatment are the most important factors relating to oxidative stress in haemodialysis patients.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 26 条
[1]  
ACWORTH IN, 1995, HDB OXIDATIVE METABO, P1
[2]   ACTION OF HYPOCHLOROUS ACID ON THE ANTIOXIDANT PROTECTIVE ENZYMES SUPEROXIDE-DISMUTASE, CATALASE AND GLUTATHIONE-PEROXIDASE [J].
ARUOMA, OI ;
HALLIWELL, B .
BIOCHEMICAL JOURNAL, 1987, 248 (03) :973-976
[3]   COMPARATIVE MORTALITY FROM CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
BROWN, JH ;
HUNT, LP ;
VITES, NP ;
SHORT, CD ;
GOKAL, R ;
MALLICK, NP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1136-1142
[4]   Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure [J].
CeballosPicot, I ;
WitkoSarsat, V ;
MeradBoudia, M ;
Nguyen, AT ;
Thevenin, M ;
Jaudon, MC ;
Zingraff, J ;
Verger, C ;
Jungers, P ;
DescampsLatscha, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :845-853
[5]   Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation [J].
Cristol, JP ;
Bosc, JY ;
Badiou, S ;
Leblanc, M ;
Lorrho, R ;
Descomps, B ;
Canaud, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) :2312-2317
[6]   Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin [J].
Dai, LI ;
Winyard, PG ;
Zhang, Z ;
Blake, DR ;
Morris, CJ .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (03) :223-228
[7]   EVALUATION OF RED-BLOOD-CELL LIPOPEROXIDATION IN HEMODIALYZED PATIENTS DURING ERYTHROPOIETIN THERAPY SUPPLEMENTED OR NOT WITH IRON [J].
DELMASBEAUVIEUX, MC ;
COMBE, C ;
PEUCHANT, E ;
CARBONNEAU, MA ;
DUBOURG, L ;
DEPRECIGOUT, V ;
APARICIO, M ;
CLERC, M .
NEPHRON, 1995, 69 (04) :404-410
[8]   ESTABLISHING THE RELATIONSHIP BETWEEN COMPLEMENT ACTIVATION AND STIMULATION OF PHAGOCYTE OXIDATIVE-METABOLISM IN HEMODIALYZED PATIENTS - A RANDOMIZED PROSPECTIVE-STUDY [J].
DESCAMPSLATSCHA, B ;
GOLDFARB, B ;
NGUYEN, AT ;
LANDAIS, P ;
LONDON, G ;
HAEFFNERCAVAILLON, N ;
JACQUOT, C ;
HERBELIN, A ;
KAZATCHKINE, M .
NEPHRON, 1991, 59 (02) :279-285
[9]   Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia [J].
Kontush, A ;
Reich, A ;
Baum, K ;
Spranger, T ;
Finckh, B ;
Kohlschutter, A ;
Beisiegel, U .
ATHEROSCLEROSIS, 1997, 129 (01) :119-126
[10]   Atherosclerosis and arteriosclerosis in chronic renal failure [J].
London, GM ;
Drueke, TB .
KIDNEY INTERNATIONAL, 1997, 51 (06) :1678-1695